Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults

NCT ID: NCT07116837

Last Updated: 2026-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

3500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2026-07-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the Aim 2 study is to assess the perceived effectiveness of vaping prevention ads among adolescents and young adults and identify which features of video ads predict perceived message effectiveness. Participants will include adolescents aged 13-17 and young adults aged 18-20 who live in the US and who are susceptible to vaping or who currently vape. In an online survey, participants will be randomized to view five randomly selected vaping prevention ads identified from a previous content analysis. After viewing the videos, participants will rate each video on the perceived message effectiveness scale and respond to questions about vaping appeal and urge to vape. The survey will take 15-20 minutes.

A follow-up survey of a subset of participants will be conducted around two weeks after they have been exposed to vaping prevention video ads in the baseline survey. Participants will view a total of six videos, including the five videos they watched previously, shown one at a time, along with one "decoy" video ad. After watching each video ad, participants will indicate whether they remember seeing the ad in the survey they took around two weeks prior. The survey will take 10-15 minutes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Health communication campaigns are a scientific approach for preventing and reducing tobacco product use among adolescents. Although a growing number of studies have examined the effects of e-cigarette communication among young adults, there is only a modest number of published studies targeting adolescents. There is little information about the objective features of vaping prevention video ads. Additionally, the follow-up study will explore how ad features are associated with recognition.

Setting: This study is an online survey of adolescents and young adults (age 13-20) who are susceptible to vaping or who currently vape and live in the United States.

Recruitment and Informed Consent: Adolescent and young adult participants will be recruited by Qualtrics Services. Participants who are 18 to 20 years old and are eligible for the study will view a consent form as part of the survey and check a box to indicate that they agree to participate in the study. For minor participants, Qualtrics will recruit parents of 13-17-year-olds, so they will receive the survey invitation with the parental permission/consent form. From there, parents will be asked to pass the survey to their child. Once the participant has completed the consent/assent process, they will be able to begin the survey.

Procedures: up to 3,500 adolescents and young adults who are susceptible to vaping or currently vape will be randomized to view 5 randomly selected ads from a pool of vaping prevention video ads identified from previous study activities. Participants will be screened for susceptibility to vaping or current vape use. Participants will then answer questions on demographic information and tobacco product use. They will view 5 videos, 1 at a time ,randomly assigned from the larger pool of videos. After viewing the videos, participants will rate each video on perceived message effectiveness (primary outcome) and respond to questions about vaping appeal and urge to vape (secondary outcomes). Finally, participants will respond to standard questions on psychological distress, tobacco product use in the home, and general health-related questions. After the survey, participants will view a debrief page with information about tobacco use harms. The survey will take 15-20 minutes.

For the follow-up study, a subset of participants will be asked to complete another survey around two weeks after they have been exposed to vaping prevention video ads in the first survey. In this survey, participants will view a total of six videos, including the five videos they watched when taking the Aim 2 survey around two weeks earlier, shown one at a time, along with one "decoy" video ad. The order of the videos will be randomized. After watching each video ad, participants will indicate whether they remember seeing the ad in the survey they took around two weeks prior. The follow-up survey will take 10-15 minutes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaping

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vaping

Adolescents and young adults who are susceptible to vaping or currently vape.

Group Type EXPERIMENTAL

Vaping prevention video ads

Intervention Type BEHAVIORAL

Participants will view and rate 5 vaping prevention video ads. The vaping prevention video ads cover a variety of different topics and were identified in a previous study activity.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vaping prevention video ads

Participants will view and rate 5 vaping prevention video ads. The vaping prevention video ads cover a variety of different topics and were identified in a previous study activity.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 13-20 years old
* Current vaper (defined as using e-cigarettes in the past 30 days) or susceptible to vaping. Participants will be considered 'susceptible to vaping' if they answer anything other than "definitely not" to 3 screening items assessing their susceptibility to vaping. An example item is, "If one of your best friends were to offer you a vape, would you use it?" (Definitely not, probably not, probably yes, definitely yes).
* Live in the United States

Exclusion Criteria

• Live outside of the United States
Minimum Eligible Age

13 Years

Maximum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

Food and Drug Administration (FDA)

FED

Sponsor Role collaborator

UNC Lineberger Comprehensive Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sarah Kowitt, PhD

Role: PRINCIPAL_INVESTIGATOR

UNC Lineberger Comprehensive Cancer Center

Seth Noar, PhD

Role: PRINCIPAL_INVESTIGATOR

UNC Lineberger Comprehensive Cancer Center

Youjin Jang, PhD

Role: PRINCIPAL_INVESTIGATOR

UNC Lineberger Comprehensive Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of North Carolina, Chapel Hill

Chapel Hill, North Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sarah Kowitt, PhD

Role: CONTACT

919-962-4075

Seth Noar, PhD

Role: CONTACT

919-962-4075

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Seth Noar, PhD

Role: primary

919-962-4075

Sarah Kowitt, PhD

Role: backup

9199624075

Related Links

Access external resources that provide additional context or updates about the study.

http://unclineberger.org/patientcare/clinical-trials/clinical-trials

UNC Lineberger Comprehensive Cancer Center Clinical Trials

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

24-2140

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effective Ads for Quitting Smoking
NCT06485479 COMPLETED NA
Message Framing for Telephone Quitline Callers
NCT00589277 COMPLETED PHASE1/PHASE2